Wealthspire Advisors (New York)
RDY icon

Wealthspire Advisors (New York)’s Dr. Reddy's Laboratories RDY Stock Holding History

Wealthspire Advisors (New York)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-399
Closed -$5.58K – 2455
2025
Q3 		$5.58K Buy
+399
New +$5.74K ﹤0.01% 2285
2019
Q1 		– Sell
-175
Closed -$1K – 630
2018
Q4 		$1K Buy
+175
New +$1.23K ﹤0.01% 829

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wealthspire Advisors (New York)'s RDY Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 399 shares — an estimated $5.58K sold.

Wealthspire Advisors (New York) first reported a position in RDY in Q4 2018 and held it in 2 quarters. The position peaked at $5.58K in Q3 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 399 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $5.58K.
  • Wealthspire Advisors (New York) first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s Dr. Reddy's Laboratories position peaked at $5.58K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.